ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Adaptimmune Therapeutics PLC

Adaptimmune Therapeutics PLC (ADAP)

0.58
-0.008
( -1.36% )
Updated: 13:18:57

Adaptimmune Therapeutics PLC Financial Summary

The current ADAP market cap is 148.41M. The company's latest EPS is USD -0.4450 and P/E is -1.30.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 7.32M231k5.68M128.23M40.9M
Operating Income -46.3M-28.32M-49.02M68.57M-11.25M
Net Income -45.6M-47.92M-48.5M69.52M-17.62M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.12M3.96M6.15M27.15M60.28M
Operating Income -138.62M-133.58M-157.85M-166.4M-118.3M
Net Income -137.17M-130.09M-158.09M-165.46M-113.87M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 296.64M282.62M258.01M321.7M317.44M
Total Liabilities 208.51M243.1M233.64M225.43M237.45M
Total Equity 88.13M39.51M24.38M96.27M79.99M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 181.54M451.14M469.55M328.92M282.62M
Total Liabilities 57.91M109.92M263.59M247.04M243.1M
Total Equity 123.64M341.23M205.96M81.88M39.51M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -126.2M-140.88M-31.95M15.45M-39M
Investing 108.34M176.54M-358k-1.1M-67.12M
Financing 806k880k29.24M53.75M78.75M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -112.51M-53.59M10.73M-141.77M-140.88M
Investing 94.95M-278.92M75.8M89.14M176.54M
Financing 366k340.05M3.29M12.87M880k
Market Cap 148.41M
Price to Earnings Ratio -1.30
Price to Sales Ratio 2.46
Price to Cash Ratio 1.03
Price to Book Ratio 3.76
Dividend Yield -

Share Statistics

Shares Outstanding 255.88M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.04 (6.45%)

Company Info

Company Name Adaptimmune Therapeutics PLC
Address 60 jubilee avenue
oxfordshire OX14 4RX
Website https://www.adaptimmune.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock